STUDY DESIGNS FOR DOSE-RANGING

被引:86
作者
SHEINER, LB
BEAL, SL
SAMBOL, NC
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,SCH MED,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,SCH PHARM,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1038/clpt.1989.108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:63 / 77
页数:15
相关论文
共 15 条
[1]  
Beal S, 1989, NONMEM USERS GUIDES
[2]   POPULATION PHARMACOKINETIC DATA AND PARAMETER-ESTIMATION BASED ON THEIR 1ST 2 STATISTICAL MOMENTS .1. [J].
BEAL, SL .
DRUG METABOLISM REVIEWS, 1984, 15 (1-2) :173-193
[3]  
BOX GEP, 1958, ANN MATH STAT, V29, P160
[4]  
FRESTON JW, 1986, AM J GASTROENTEROL, V10, P307
[5]   2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS [J].
GRIZZLE, JE .
BIOMETRICS, 1965, 21 (02) :467-&
[6]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[7]  
KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI
[8]  
LEWIS P, 1969, IBM SYST J, V8, P135
[9]  
SAMBOL N, IN PRESS S AM ASS PH
[10]  
STEIMER JL, 1984, VARIABILITY DRUG THE, P65